Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Ropivacaine Concentration for Femoral Nerve Blocks
NCT00923598Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Jun 2009
- Primary completion
- Apr 2011
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by University of California, San Diego. Primary endpoint: Quadriceps Femoris Muscle Strength Maximum Voluntary Isometric Contraction. Started Jun 2009; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00923598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00923598.